The phrase "average weight reduction" is correct and usable in written English.
It can be used in contexts discussing changes in weight, such as in health, fitness, or scientific studies.
Example: "The study reported an average weight reduction of 5 pounds among participants who followed the diet plan for three months."
Alternatives: "mean weight loss" or "typical weight decrease".
The average weight reduction for those who lasted six months but had no friends in the network was 4.1%.
And yes, it translated into a change in B.M.I: the average weight reduction found (after about six months of light-rail use) was 1.18 B.M.I. points.
Average weight reduction was similar in both groups: −0.5 kg (≥75 years) and −0.6 kg (<75 years).
Weight loss ≥ 5% was found in 18.1%–22.1% of patients on dapagliflozin, with an average weight reduction of 2.2 2.9 kg, whereas patients on placebo achieved only a 0.9 kg decrease over 24 weeks.
14, 26– 35 The head-to-head study versus glimepiride on the background of metformin demonstrated an average weight reduction of −4.1% (−3.6 kg) and −4.2% (−3.6 kg) with canagliflozin 100 mg and 300 mg after 104 weeks compared with a weight gain of approximately 0.9% (0.8 kg) with glimepiride.
3 4 5 Meta-analyses of sibutramine and orlistat trials report average weight reductions of 3 kg to 5 kg, but some of the included trials had attrition rates of up to 50% that were possibly due to adverse events, suggesting that the interventions could be less effective in clinical practice.
32 The use of canagliflozin as add-on to insulin (≥30 IU/d) led to average weight reductions of approximately −2.4% (−2.3 kg) and −3.1% (−3.0 kg) after 52 weeks with canagliflozin 100 mg and 300 mg, respectively; the mean insulin dose at baseline was 83 IU/d and did not change over 52 weeks for the majority of patients.
It was also shown that fabricated and tapered frames achieved an average percentage weight reduction of 9% and 11%, respectively, as compared to comparable hot-rolled steel frames.
Participants in both arms achieved an average 3.4% weight reduction but did not reduce A1C.
81 Rimonabant was consistently associated with an average additional weight reduction of 4.9 kg (dose of 20 mg) and 1.3 kg (dose of 5 mg) compared to placebo.
In susceptible cultivars, reduction in seed and herbage yields, and almost complete defoliation and premature death has been reported [ 3, 4], with infected cultivars exhibiting an average seed weight reduction of 37.3% [ 5].
